These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22732249)

  • 21. The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.
    Hellum M; Franco-Lie I; Øvstebø R; Hauge T; Henriksson CE
    PLoS One; 2017; 12(9):e0184579. PubMed ID: 28910348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.
    Helmond SE; Catalfamo JL; Brooks MB
    Am J Vet Res; 2013 Feb; 74(2):207-15. PubMed ID: 23363344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
    Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
    Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
    Basavaraj MG; Olsen JO; Østerud B; Hansen JB
    Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
    Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant effects of an antidiabetic drug on monocytes in vitro.
    Henriksson CE; Hellum M; Haug KB; Aass HC; Joø GB; Øvstebø R; Trøseid AM; Klingenberg O; Kierulf P
    Thromb Res; 2011 Nov; 128(5):e100-6. PubMed ID: 21862110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo coagulation test on tissue factor-expressing cells with a calibrated automated thrombogram.
    Takamiya O; Sakata M
    Lab Hematol; 2008; 14(4):39-44. PubMed ID: 19095614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
    Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
    Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.
    Chou ML; Lin LT; Devos D; Burnouf T
    Transfusion; 2015 Oct; 55(10):2433-44. PubMed ID: 25988671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
    Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
    Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
    Christersson C; Lindahl B; Siegbahn A
    Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma: a pilot study.
    Maly M; Hrachovinova I; Tomasov P; Salaj P; Hajek P; Veselka J
    Eur J Haematol; 2009 Feb; 82(2):148-53. PubMed ID: 19018869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
    Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
    Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
    Boknäs N; Faxälv L; Lindahl TL; Ramström S
    J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism.
    Manly DA; Wang J; Glover SL; Kasthuri R; Liebman HA; Key NS; Mackman N
    Thromb Res; 2010 Jun; 125(6):511-2. PubMed ID: 19854471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
    Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlative analysis of nanoparticle tracking, flow cytometric and functional measurements for circulating microvesicles in normal subjects.
    Enjeti AK; Ariyarajah A; D'Crus A; Seldon M; Lincz LF
    Thromb Res; 2016 Sep; 145():18-23. PubMed ID: 27429418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.